Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
-
Thunder Power Reports Unaudited Third Quarter 2024 Financial Results
-
Artera Celebrates Executive Promotions and Multiple New Industry Accolades
-
Canadian North Resources Inc. Announces Appointment Of Henderson Tse To The Board Of Directors
-
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
-
iPower Reports Fiscal First Quarter 2025 Results
-
Alumis Presents Data Highlighting ESK-001’s Potential as a High-efficacy Oral Treatment for Systemic Lupus Erythematosus (SLE) at ACR Convergence 2024
-
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
-
T2 Biosystems Announces Third Quarter 2024 Financial Results
-
Aqua Metals Announces Progress on Operational Achievements and Ongoing Commercial Development, Reports Third Quarter 2024 Results
-
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
-
Rekor Systems Reports Third Quarter 2024 Financial Results
-
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
-
Vuzix Reports Third Quarter 2024 Results
-
Perimeter Medical Imaging AI Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary
-
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update
-
Research Solutions Reports Fiscal First Quarter 2025 Results
-
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025
-
4Front Ventures Reports Third Quarter 2024 Results
-
Perfect Moment Reports Fiscal Q2 2025 Results
-
Starco Brands Reports Third Quarter 2024 Financial Results
-
Zillow Group Promotes Jun Choo to chief operating officer
-
Hyliion Holdings Reports Third-Quarter 2024 Financial Results
-
Twilio Announces Upcoming 2025 Investor Day
-
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024
-
Docusign Announces Timing of Third Quarter Fiscal 2025 Earnings Conference Call
-
Fortune and Great Place To Work® Name Cadence One of the World’s Best Workplaces™ in 2024, Ranking No. 9
-
Allied Gaming & Entertainment Announces Third Quarter 2024 Financial Results
-
Flex Acquires JetCool to Expand Data Center and Power Portfolio
-
Trinity Industries, Inc. to Present at the 2024 Stephens Annual Investment Conference
-
Interface Declares Regular Quarterly Dividend
-
Kodiak Gas Services Announces Public Offering of Common Stock by Selling Stockholder
-
Surf Air Mobility Reports Third Quarter Financial Results, Exceeding Revenue and Adjusted EBITDA Expectations
-
GCT Semiconductor Holding, Inc. Reports Third Quarter 2024 Financial Results
-
Movano Health Reports Q3 2024 Financial Results and Provides Business Update
-
ReposiTrak Delivers First Fiscal Quarter Revenue of $5.4 Million and Earnings Per Share of $0.09
-
Stonegate Capital Partners Initiates Coverage on EnSilica PLC (AIM: ENSI)
-
Digimarc Reports Third Quarter 2024 Financial Results
-
National Storage Affiliates Trust Announces Quarterly Dividends
-
Palantir Announces Transfer of Stock Exchange Listing to Nasdaq
-
Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results
-
Visa to Participate in Upcoming Investor Conference
-
Expion360 Reports Third Quarter 2024 Financial Results
-
Lesaka gets green light to launch Employee Share Ownership Plan
-
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
-
RYVYL Reports Q3 2024 Results
-
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update

